← 治験一覧に戻る
網膜静脈分枝閉塞症による黄斑浮腫に対するラニビズマブのPRN投与レジメンの有用性の評価
基本情報
- NCT ID
- NCT02478515
- ステータス
- 完了
- 試験のフェーズ
- 第4相
- 試験タイプ
- 介入
- 目標被験者数
- 27
- 治験依頼者名
- Nagoya City University
概要
Monthly intravitreal ranibizumab (IVR) during the first 6 month had great effect for macular edema with branch retinal vein occlusion (BVO) both in visual and anatomical outcome. It is expected that similar results could be obtained by less frequent IVR. The purpose of this study is to investigate if IVR by PRN is as effective as by monthly. In addition, the investigators are going to study the relationship between macular edema and the size and location of retinal non-perfusion area.
対象疾患
Branch Retinal Vein Occlusion
介入
Ranibizumab(DRUG)
依頼者(Sponsor)
ノバルティスファーマ株式会社(INDUSTRY)
Nagoya City University(OTHER)
実施施設 (1)
名古屋市立大学病院
Nagoya, Aichi-ken, Japan